Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank78
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-9.55M
↑ 66% vs avg
Percentile
P78
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-28.39M
Historical baseline
PeriodValueYoY Change
TTM$-9.55M+85.5%
2024$-65.90M-6.0%
2023$-62.20M-188.0%
2022$-21.60M+28.8%
2021$-30.31M+23.1%
2020$-39.43M-41.1%
2019$-27.95M-35.5%
2018$-20.63M-362.8%
2017$-4.46M-133.0%
2016$-1.91M-